These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31746355)

  • 1. Exploratory study on application of MALDI‑TOF‑MS to detect serum and urine peptides related to small cell lung carcinoma.
    Lv P; Liu Z; Xu B; Tang C; Li X; Qin H; Yang S; Gao H; He K; Liu X
    Mol Med Rep; 2020 Jan; 21(1):51-60. PubMed ID: 31746355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
    An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
    Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of serum peptide biomarker for ovarian cancer diagnosis by Clin-TOF-II-MS combined with magnetic beads technology].
    Xiu L; Li N; Wang WP; Chen F; Yuan GW; Sun YC; Zhang R; Li XG; Zuo J; Li N; Cui W; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1188-1195. PubMed ID: 34794222
    [No Abstract]   [Full Text] [Related]  

  • 6. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
    Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
    Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and significance of serum protein markers of small-cell lung cancer.
    Han M; Liu Q; Yu J; Zheng S
    J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
    He J; Zeng ZC; Xiang ZL; Yang P
    World J Gastroenterol; 2014 Mar; 20(11):3025-32. PubMed ID: 24659894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer.
    Du J; Yang S; Lin X; Bu L; Nan Y; Huo S; Shang W
    Diagn Pathol; 2010 Sep; 5():60. PubMed ID: 20854674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
    Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine peptide patterns for non-invasive diagnosis of endometriosis: a preliminary prospective study.
    Wang L; Liu HY; Shi HH; Lang JH; Sun W
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():23-8. PubMed ID: 24694773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
    Wang L; Tang C; Xu B; Yang L; Qu L; Li L; Li X; Wang W; Qin H; Gao H; He K; Liu X
    PLoS One; 2017; 12(6):e0179000. PubMed ID: 28594947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of differential proteins in patients with peripheral lung cancer by surface-enhanced laser desorption/ionization time of flight mass technology].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):30-3. PubMed ID: 21429416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer.
    Ding D; Chen M; Xiao X; Cao P; Li S
    Int J Biol Markers; 2020 Sep; 35(3):59-66. PubMed ID: 32701013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.
    Tao YL; Li Y; Gao J; Liu ZG; Tu ZW; Li G; Xu BQ; Niu DL; Jiang CB; Yi W; Li ZQ; Li J; Wang YM; Cheng ZB; Liu QD; Bai L; Zhang C; Zhang JY; Zeng MS; Xia YF
    J Cell Biochem; 2012 Jul; 113(7):2268-78. PubMed ID: 22334501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.